SK Growth Opportunities (SKGR) 10-Q 12 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 12, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Fiscal Year Focus	2023
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Registrant Name	SK Growth Opportunities Corporation
Entity Central Index Key	0001912461
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	E9
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity File Number	001-41432
Entity Tax Identification Number	98-1643582
Entity Address, Address Line One	228 Park Avenue S #96693
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10003
City Area Code	917
Local Phone Number	599-1622
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-half of one redeemable warrant
Trading Symbol	SKGRU
Security Exchange Name	NASDAQ
Class A ordinary shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		20,960,000
Title of 12(b) Security	Class A Ordinary Shares included as part of the units
Trading Symbol	SKGR
Security Exchange Name	NASDAQ
Class B ordinary shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		5,240,000
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
Trading Symbol	SKGRW
Security Exchange Name	NASDAQ

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 373,307	$ 515,410
Prepaid expenses	464,500	415,866
Total current assets	837,807	931,276
Non-current assets:
Prepaid expenses—non-current	102,375	204,750
Investments held in Trust Account	219,946,528	217,645,818
Total non-current assets	220,048,903	217,850,568
Total Assets	220,886,710	218,781,844
Current liabilities:
Accounts payable	24,029	2,331
Accrued expenses	374,990	300,481
Overfunding loan	5,240,000	5,240,000
Total current liabilities	5,639,019	5,542,812
Non-current liabilities:
Deferred underwriting and advisory fees	7,336,000	7,336,000
Total non-current liabilities	7,336,000	7,336,000
Total liabilities	12,975,019	12,878,812
Commitments and Contingencies
Shareholders' Deficit:
Preference shares, $0.0001 par value; 990,000 shares authorized; none issued or outstanding as of March 31, 2023 and December 31, 2022
Additional paid-in capital	0
Accumulated deficit	(11,935,361)	(11,643,310)
Total shareholders' deficit	(11,934,837)	(11,642,786)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	220,886,710	218,781,844
Class A ordinary shares [Member]
Non-current liabilities:
Class A ordinary shares, $0.0001 par value; 9,000,000,000 shares authorized; 20,960,000 shares subject to possible redemption at approximately $10.49 and $10.38 per share as of March 31, 2023 and December 31, 2022, respectively	219,846,528	217,545,818
Shareholders' Deficit:
Common stock
Class B ordinary shares [Member]
Shareholders' Deficit:
Common stock	$ 524	$ 524

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preference shares, Par value	$ 0.0001	$ 0.0001
Preference shares, Shares authorized	990,000	990,000
Preference shares, Issued	0	0
Preference shares, Outstanding	0	0
Class A ordinary shares [Member]
Temporary equity, Shares outstanding	20,960,000	20,960,000
Temporary equity, Redemption per share	$ 10.49	$ 10.38
Common stock, Par or stated value per share	$ 0.0001	$ 0.0001
Common stock, Shares authorized	9,000,000,000	9,000,000,000
Common stock, Shares issued	0	0
Common stock, Shares outstanding	0	0
Temporary equity, Par or stated value per share	$ 0.0001	$ 0.0001
Temporary equity, shares authorized	9,000,000,000	9,000,000,000
Class B ordinary shares [Member]
Common stock, Par or stated value per share	$ 0.0001	$ 0.0001
Common stock, Shares authorized	999,000,000	999,000,000
Common stock, Shares issued	5,240,000	5,240,000
Common stock, Shares outstanding	5,240,000	5,240,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
General and administrative expenses		$ 292,051	$ 37,032
Loss from operations		(292,051)	(37,032)
Other income:
Income from investments held in Trust Account		2,300,710	0
Total other income		2,300,710	0
Net income (loss)		2,008,659	(37,032)
Class A ordinary shares [Member]
Other income:
Net income (loss)		$ 1,606,927	$ 0
Basic weighted average shares outstanding		20,960,000	0
Diluted weighted average shares outstanding		20,960,000	0
Basic net income (loss) per share		$ 0.08	$ 0
Diluted net income (loss) per share		$ 0.08	$ 0
Class B ordinary shares [Member]
Other income:
Net income (loss)		$ 401,732	$ (37,032)
Basic weighted average shares outstanding	[1]	5,240,000	5,000,000	[2]
Diluted weighted average shares outstanding	[1]	5,240,000	5,000,000	[2]
Basic net income (loss) per share		$ 0.08	$ (0.01)
Diluted net income (loss) per share		$ 0.08	$ (0.01)
[1]On May 5, 2022, 1,437,500 Class B ordinary shares were surrendered and thereupon cancelled by the Company resulting in a decrease in the total number of Class B ordinary shares outstanding from 7,187,500 shares to 5,750,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (Note 4).[2]This number excludes an aggregate of up to 750,000 Class B ordinary shares that was subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter (Note 4).

Condensed Statements of Opera_2

Condensed Statements of Operations (Parenthetical) - Class B ordinary shares [Member] - shares	3 Months Ended
	Mar. 31, 2022	May 05, 2022
Number of shares cancelled		1,437,500
Common stock, Shares outstanding		5,750,000
Weighted average number of shares, common stock subject to repurchase or cancellation	750,000
Previously Reported [Member]
Common stock, Shares outstanding		7,187,500

Condensed Statements of Changes

Condensed Statements of Changes In Shareholders' Deficit - USD ($)		Total	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Class B ordinary shares [Member]	Class B ordinary shares [Member] Common Stock [Member]
Beginning Balance at Dec. 31, 2021		$ (8,831)	$ 24,425	$ (33,831)		$ 575	[1],[2]
Beginning Balance, Shares at Dec. 31, 2021	[1],[2]					5,750,000
Net income (loss)		(37,032)		(37,032)	$ (37,032)
Ending Balance at Mar. 31, 2022		(45,863)	24,425	(70,863)		$ 575	[1],[2]
Ending Balnace, Shares at Mar. 31, 2022	[1],[2]					5,750,000
Beginning Balance at Dec. 31, 2022		(11,642,786)	0	(11,643,310)		$ 524
Beginning Balance, Shares at Dec. 31, 2022						5,240,000
Accretion for Class A ordinary shares to redemption amount		(2,300,710)	0	(2,300,710)
Net income (loss)		2,008,659		2,008,659	$ 401,732
Ending Balance at Mar. 31, 2023		$ (11,934,837)	$ 0	$ (11,935,361)		$ 524
Ending Balnace, Shares at Mar. 31, 2023						5,240,000
[1]On May 5, 2022, 1,437,500 Class B ordinary shares were surrendered and thereupon cancelled by the Company resulting in a decrease in the total number of Class B ordinary shares outstanding from 7,187,500 shares to 5,750,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (Note 4).[2]This number excludes an aggregate of up to 750,000 Class B ordinary shares that was subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter (Note 4).

Condensed Statements of Chang_2

Condensed Statements of Changes In Shareholders' Deficit (Parenthetical) - Class B ordinary shares [Member]	May 05, 2022 shares
Number of shares cancelled	1,437,500
Shares outstanding	5,750,000
Previously Reported [Member]
Shares outstanding	7,187,500

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 2,008,659	$ (37,032)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Income from investments held in Trust Account	(2,300,710)	0
Changes in operating assets and liabilities:
Prepaid expenses	53,741	0
Accounts payable	21,698	3,900
Accrued expenses	74,509	(5,231)
Net cash used in operating activities	(142,103)	(38,363)
Cash Flows from Financing Activities:
Proceeds from note payable to related party	0	300,000
Deferred offering costs paid		(99,717)
Net cash provided by financing activities	0	200,283
Net change in cash	(142,103)	161,920
Cash—beginning of the period	515,410
Cash—end of the period	373,307	161,920
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accrued expenses	$ 0	$ 301,365

Description of Organization, Bu

Description of Organization, Business Operations, Liquidity and Basis of Presentation	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization, Business Operations, Liquidity and Basis of Presentation	Note 1—Description of Organization, Business Operations, Liquidity and Basis of Presentation SK Growth Opportunities Corporation (the “Company”) is a blank check company incorporated in Cayman Islands on December 8, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of March 31, 2023, the Company had not commenced any operations. All activity for the period from December 8, 2021 (inception) through March 31, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, its search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating The Company’s sponsor is Auxo Capital Managers LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on June 23, 2022. On June 28, 2022, the Company consummated its Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting commissions (see Note 5). The underwriter was granted a 45-day (as defined in Note 4). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,600,000 warrants of the Company (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating proceeds of $6.6 million (see Note 4). Substantially concurrently with the closing of the Partial Over-Allotment Exercise, the Company completed the sale of 192,000 additional Private Placement Warrants to the Sponsor (the “Additional Private Placement”) at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $192,000. In addition, upon the consummation of the Initial Public Offering on June 28, 2022, the Sponsor provided the Company with the First Overfunding Loan (as defined in Note 4) in the amount of $5.0 million to deposit in the Trust Account at no interest. In connection with the Partial Over-Allotment Exercise on July 20, 2022, the Sponsor provided the Company with the Second Overfunding Loan (as defined in Note 4) in the amount of $240,000 to deposit in the Trust Account. Upon the closing of the Initial Public Offering and the Partial Over-Allotment Exercise, approximately $214.8 million ($10.25 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering, the Partial Over-Allotment Exercise the proceeds of the Overfunding Loans and certain of the proceeds of the Private Placement and the Additional Private Placement, was placed in a trust account (the “Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the sale of Private Placement Warrants and the proceeds from the Overfunding Loan, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting discounts held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the Company’s Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.25 per Public Share). The per-share The Public Shares are recognized at redemption value and classified as temporary equity, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares included in the Units issued in the Company’s Initial Public Offering, without the prior consent of the Company. The holders of the Founder Shares (the “initial shareholders”) agreed not to propose an amendment to the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial The Company will have 18 months from the closing of the Initial Public Offering to consummate an initial Business Combination, or December 28, 2023 (or 21 months if the Company has executed a definitive agreement relating to an initial Business Combination) (the “Combination Period”). If the Company anticipates that it may not be able to consummate the initial Business Combination within 18 months (or 21 months, if applicable) from the consummation of the Initial Public Offering, the Company may, by resolution of the board of directors if requested by the Sponsor, extend the period of time the Company will have to consummate an initial Business Combination up to two additional three-month periods (for a total of up to 24 months from the closing of the Initial Public Offering); subject to the Sponsor depositing additional funds into the Trust Account as set out below. Notwithstanding the foregoing, in no event will the Company have more than 24 months from the closing of the Initial Public Offering to consummate an initial Business Combination. The Public Shareholders will not be entitled to vote on or redeem their shares in connection with any such extension. For each such extension, the Sponsor (or its designees) must deposit into the Trust Account, under the form of loan (the “Extension Loans”), funds equal to $0.10 per Unit, or $2,096,000, for up to an aggregate of $4,192,000, on or prior to the date of the applicable deadline for each three-month extension. If the Company is unable to consummate an initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The initial shareholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive its rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.25. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.25 per Public Share or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. On August 10, 2022, the Company announced that, effective August 15, 2022, the Company’s Class A ordinary shares and warrants comprising each issued and outstanding Unit will commence trading separately under the ticker symbols “SKGR” and “SKGW,” respectively. Holders of Units may elect to continue to hold Units or separate their Units into the component securities. Going Concern Consideration As of March 31, 2023, the Company had approximately $373,000 in cash and working capital deficit of approximately $4.8 million. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to purchase Founder Shares, and loan proceeds from the Sponsor of $300,000 under the Note (as defined in Note 4). The Company repaid the Note in full upon closing of the Initial Public Offering. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, the Overfunding Loans and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may provide the Company with Working Capital Loans (as defined in Note 4) as may be required (of which up to $1.5 million may be converted at the lender’s option into warrants). Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or through liquidation date. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued expenses, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. Management plans to address this uncertainty through the initial Business Combination as discussed above. There is no assurance that the Company’s plans to consummate the initial Business Combination will be successful or successful within the Combination Period (by December 28, 2023). The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has In February 2022, the Russian Federation commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of the condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of the condensed financial statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and Article 8 of Regulation S-X. Accordingly, The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Form 10-K as Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of March 31, 2023 and December 31, 2022, the assets held in the Trust Account were in money market funds. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company evaluates its financial instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For freestanding derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent changes in fair value recognized in the statements of operations each reporting period. The classification of freestanding derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of each reporting period. The Company evaluates embedded conversion features within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from the debt host instrument and accounted for as a derivative in accordance with ASC 815. The Company accounted for the warrants issued in the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in ASC 815. Application of such guidance provides that the warrants are not precluded from equity classification. The warrants were initially measured at fair value. Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. The Partial Over-allotment option was recognized as a derivative liability in accordance with ASC 815. Accordingly, the Company recognized the instrument as a liability at fair value and adjusted the instrument to fair value at each reporting period. On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and advisory fees and other costs incurred through the condensed balance sheet date that are directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the warrants were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2023 and December 31, 2022, 20,960,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in As of March 31, 2023 and December 31, 2022, the amount of Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table: Gross proceeds $ 209,600,000 Less: Proceeds allocated to Public Warrants (3,144,000 ) Proceeds allocated to over-allotment option (20,794 ) Class A ordinary shares issuance costs (12,369,649 ) Plus: Accretion of carrying value to redemption value 23,480,261 Class A ordinary shares subject to possible redemption, December 31, 2022 217,545,818 Plus: Accretion of carrying value to redemption value 2,300,710 Class A ordinary shares subject to possible redemption, March 31, 2023 $ 219,846,528 Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Remeasurement associated with the redeemable Class A ordinary shares is excluded from net income (loss) per ordinary share as the redemption value approximates fair value. Therefore, the net income (loss) per ordinary share calculation allocates income shared pro rata between Class A and Class B ordinary shares. The Company has not considered the effect of the exercise of the Public Warrants and Private Placement Warrants to purchase an aggregate o The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Three Months Ended March 31, 2023 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ 1,606,927 $ 401,732 $ — $ (37,032 ) Denominator: Weighted average ordinary shares outstanding—basic and diluted 20,960,000 5,240,000 — 5,000,000 Net income (loss) per ordinary share—basic and diluted $ 0.08 $ 0.08 $ — $ (0.01 ) Stock Compensation The Company accounts for stock-based compensation expense in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Initial Public Offering	Note 3—Initial Public Offering On June 28, 2022, the Company consummated its Initial Public Offering of 20,000,000 Units, at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting commissions. The underwriter was granted the Over-Allotment Option to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On July 20, 2022, pursuant to the underwriter’s notice of the partial exercise of the Over-Allotment Option, the Company sold an additional 960,000 Units, at $10.00 per Unit, generating aggregate additional gross proceeds of $9.6 million to the Company. The remaining Over-Allotment Option expired on August 7, 2022. Each Unit consists of one share of Class A ordinary shares, and one-half of one

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 4—Related Party Transactions Founder Shares On December 9, 2021, the sponsor purchased 8,625,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), to cover certain expenses on the Company’s behalf for an aggregate purchase price of $25,000. On February 24, 2022, 1,437,500 Class B ordinary shares were surrendered and thereupon cancelled by the Company. On May 5, 2022, 1,437,500 Class B ordinary shares were surrendered and thereupon cancelled by the Company resulting in a decrease in the total number of Class B ordinary shares outstanding to 5,750,000 shares. The Sponsor agreed to forfeit up to an aggregate of 750,000 Founder Shares to the extent that the option to purchase additional Units is not exercised in full by the underwriter or is reduced, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On July 20, 2022, the Company sold an additional 960,000 Units in the Partial Over-Allotment Exercise pursuant to the underwriter’s notice of the partial exercise of the Over-Allotment Option. On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares. The initial shareholders, and the executive officers and directors of the Company, agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i) one year after the completion of the initial Business Combination; and (ii) subsequent to the initial Business Combination (x) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property or (y) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, any 30-trading In February and March 2022, the Sponsor transferred an aggregate of 90,000 Class B ordinary shares to the Company’s independent director nominees. The sale of the Founder Shares is in the scope of ASC 718. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of March 31, 2023, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation will be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 6,600,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, in a private placement to the Sponsor, generating proceeds of $6.6 million. Substantially concurrently with the closing of the Partial Over-Allotment Exercise, the Company completed the Additional Private Placement of 192,000 additional Private Placement Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $192,000. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The purchasers of the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants (except to permitted transferees) until 30 days after the completion of the initial Business Combination. Related Party Loans Promissory Note to Sponsor The Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note, dated on December 9, 2021 and was later amended on May 5, 2022 (the “Note”). The Note was non-interest Overfunding Loans On June 28, 2022, in connection with the closing of the Initial Public Offering, the Sponsor loaned the Company $5.0 million under a non-interest Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2023 and December 31, 2022, the Company had no borrowings under the Working Capital Loans. Extension Loans In order to extend the time available for the Company to consummate its initial Business Combination by an additional three months each time for a total of up to 24 months to complete a Business Combination), the Sponsor or its affiliates or designees may provide an Extension Loan to the Company to provide funds to deposit into the Trust Account an additional amount of $0.10 per share each time. The Extension Loan will be provided under the form of a non-interest bearing, unsecured promissory Such Extension Loans may be converted into warrants upon the consummation of the initial business combination, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. If the Company completes the initial Business Combination, and the lender decides not to convert the Extension Loans into warrants, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, it will not repay such loans. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination. Except for the foregoing, the terms of such Extension Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2023 and December 31, 2022, the Company had no borrowings under the Extension Loans. Administrative Services Agreement On June 23, 2022, the Company entered into an agreement with an affiliate of the Sponsor, pursuant to which the Company agreed to pay such affiliate a total of $10,000 per month for secretarial and administrative support services provided to the Company through the earlier of consummation of the initial Business Combination and the Company’s liquidation. The Company incurred $30,000 in such fees included as general and administrative expenses on the accompanying unaudited condensed statements of operations fo r t 3. A In addition, the Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket of out-of-pocket expenses incurred

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5—Commitments and Contingencies Shareholder and Registration Rights Pursuant to a registration and shareholder rights agreement entered into on June 23, 2022, the holders of Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and Extension Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and Extension Loans), have registration rights to require the Company to register a sale of any of the securities held by them. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up Underwriting and Advisory Agreement The underwriter was entitled to an underwriting discount of $0.20 per Unit, or $4.0 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.35 per Unit, or approximately $7.0 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. The Company also engaged Cohen & Company Capital Markets (“CCM”) to provide consulting and advisory services to the Company in connection with the Initial Public Offering, for which it would receive (i) an advisory fee of $400,000, paid upon the closing of the Initial Public Offering, and (ii) a deferred advisory fee of $700,000 (payable solely in the event that the Company completes the initial Business Combination. The underwriter has reimbursed a portion of their fees to cover for the fees payable to CCM. In connection with the consummation of the Partial Over-Allotment Exercise, the underwriter and CCM were entitled to an additional fee in the aggregate amount of $192,000, paid upfront on July 20, 2022, and $336,000 in deferred underwriting and advisory commissions (net of the reimbursement from the underwriter to cover for the fees payable to CCM).

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	Note 6—Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit Preference Shares— Class A Ordinary Shares— Class B Ordinary Shares— Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% Warrants— The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity- linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by such shareholder) (the “Newly Issued Price”), (y) the proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of Public Warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants (i) will not be redeemable by the Company, (ii) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders (and the Class A ordinary shares issuable upon exercise of these warrants may not be transferred, assigned or sold by the holders) until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. Redemption of Public Warrants • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption, the “30-day redemption period”; • if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period The Company will not redeem the Public Warrants as described above unless (an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 7—Fair Value Measurements The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 by level within the fair value hierarchy: March 31, 2023 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account – Money Market Fund $ 219,946,528 $ — $ — December 31, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account – Money Market Fund $ 217,645,818 $ — $ — Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There was no transfer between levels during the three months ended March 31, 2023.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 8—Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and Article 8 of Regulation S-X. Accordingly, The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Form 10-K as
Use of Estimates	Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of March 31, 2023 and December 31, 2022, the assets held in the Trust Account were in money market funds.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For freestanding derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent changes in fair value recognized in the statements of operations each reporting period. The classification of freestanding derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of each reporting period. The Company evaluates embedded conversion features within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from the debt host instrument and accounted for as a derivative in accordance with ASC 815. The Company accounted for the warrants issued in the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in ASC 815. Application of such guidance provides that the warrants are not precluded from equity classification. The warrants were initially measured at fair value. Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. The Partial Over-allotment option was recognized as a derivative liability in accordance with ASC 815. Accordingly, the Company recognized the instrument as a liability at fair value and adjusted the instrument to fair value at each reporting period. On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and advisory fees and other costs incurred through the condensed balance sheet date that are directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the warrants were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2023 and December 31, 2022, 20,960,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in As of March 31, 2023 and December 31, 2022, the amount of Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table: Gross proceeds $ 209,600,000 Less: Proceeds allocated to Public Warrants (3,144,000 ) Proceeds allocated to over-allotment option (20,794 ) Class A ordinary shares issuance costs (12,369,649 ) Plus: Accretion of carrying value to redemption value 23,480,261 Class A ordinary shares subject to possible redemption, December 31, 2022 217,545,818 Plus: Accretion of carrying value to redemption value 2,300,710 Class A ordinary shares subject to possible redemption, March 31, 2023 $ 219,846,528
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Remeasurement associated with the redeemable Class A ordinary shares is excluded from net income (loss) per ordinary share as the redemption value approximates fair value. Therefore, the net income (loss) per ordinary share calculation allocates income shared pro rata between Class A and Class B ordinary shares. The Company has not considered the effect of the exercise of the Public Warrants and Private Placement Warrants to purchase an aggregate o The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Three Months Ended March 31, 2023 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ 1,606,927 $ 401,732 $ — $ (37,032 ) Denominator: Weighted average ordinary shares outstanding—basic and diluted 20,960,000 5,240,000 — 5,000,000 Net income (loss) per ordinary share—basic and diluted $ 0.08 $ 0.08 $ — $ (0.01 )
Stock Compensation	Stock Compensation The Company accounts for stock-based compensation expense in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets	As of March 31, 2023 and December 31, 2022, the amount of Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table: Gross proceeds $ 209,600,000 Less: Proceeds allocated to Public Warrants (3,144,000 ) Proceeds allocated to over-allotment option (20,794 ) Class A ordinary shares issuance costs (12,369,649 ) Plus: Accretion of carrying value to redemption value 23,480,261 Class A ordinary shares subject to possible redemption, December 31, 2022 217,545,818 Plus: Accretion of carrying value to redemption value 2,300,710 Class A ordinary shares subject to possible redemption, March 31, 2023 $ 219,846,528
Summary of basic and diluted net loss per ordinary share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Three Months Ended March 31, 2023 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ 1,606,927 $ 401,732 $ — $ (37,032 ) Denominator: Weighted average ordinary shares outstanding—basic and diluted 20,960,000 5,240,000 — 5,000,000 Net income (loss) per ordinary share—basic and diluted $ 0.08 $ 0.08 $ — $ (0.01 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Summary of assets and liabilities that are measured at fair value on a recurring basis	The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 by level within the fair value hierarchy: March 31, 2023 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account – Money Market Fund $ 219,946,528 $ — $ — December 31, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account – Money Market Fund $ 217,645,818 $ — $ —

Description of Organization, _2

Description of Organization, Business Operations, Liquidity and Basis of Presentation - Additional Information (Detail) - USD ($)					3 Months Ended	12 Months Ended
	Aug. 09, 2022	Jul. 20, 2022	Jun. 28, 2022	Dec. 09, 2021	Mar. 31, 2023	Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Company incorporation date of incorporation					Dec. 08, 2021
Sale of stock issue price per share					$ 10.25
Total offering costs incurred in connection with initial public offering			$ 12,000,000
Number of days granted to underwriters to subscribe to over-Allotment option			45 days
Deferred Underwriting Commissions			$ 7,000,000
Gross proceeds from initial public offering			$ 214,800,000
Per share value of restricted asset			$ 10.25
Percentage of obligation to redeem public shares if entity does not complete a business combination					100%
Business combination consummate period limit					185 days
Cash					$ 373,307	$ 515,410
Working capital					$ 4,800,000
Percentage of public shares that can be transferred without any restriction					15%
Period within which business combination shall be consummated from the consummation of initial public offer					18 months
Period within which business combination shall be consummated from the consummation of initial public offer if the definitive agreement executed relating to business combination					21 months
Expenses payable on dissolution					$ 100,000
Sponsor [Member] | Working Capital Loan [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Working capital loans convertible into equity warrants					1,500,000
Sponsor [Member] | Promissory Note [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from loan					$ 300,000
Sponsor [Member] | FirstOverfunding Loan [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Debt instrument, face amount			$ 5,000,000
Sponsor [Member] | Second Overfunding Loan [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Debt instrument, face amount			$ 240,000
Sponsor [Member] | Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights warrants issued during the period		192,000	6,600,000
Class of warrants or rights warrants issued issue price per warrant		$ 1	$ 1
Proceeds from issuance of warrants		$ 192,000	$ 6,600,000
Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Extended period within which business combination shall be consummated from the closing of initial public offer					24 months
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Temporary equity redemption price per share					$ 10.25
Prospective assets of acquire as a percentage of fair value of assets in the trust account					80%
Class A ordinary shares [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Gross proceeds from initial public offering						209,600,000
Proceeds from issuance of warrants						$ 3,144,000
Temporary equity redemption price per share					$ 10.49	$ 10.38
Class B ordinary shares [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common Stock Forfeitured During The Period	510,000
Class B ordinary shares [Member] | Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period value issued for services				$ 25,000	$ 25,000
Target Business [Member] | Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment ownership percentage					50%
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares			20,000,000
Gross proceeds from initial public offering			$ 200,000,000
Deferred Underwriting Commissions			$ 7,000,000
Sale of stock issue price per share			$ 10
IPO [Member] | Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Per share amount must deposit under form of extension loans into the trust account					$ 0.1
IPO [Member] | Class A ordinary shares [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares			20,000,000
Sale of stock issue price per share			$ 10
Gross proceeds from initial public offering			$ 200,000,000
Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock, shares subscribed but unissued			3,000,000
Sale of stock issue price per share			$ 10
Over-Allotment Option [Member] | Sponsor [Member] | Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights warrants issued during the period			192,000
Class of warrants or rights warrants issued issue price per warrant			$ 1
Over-Allotment Option [Member] | Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock, shares subscribed but unissued			3,000,000
Over-Allotment Option [Member] | Maximum [Member] | Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Additional amount to be deposit in the trust account if option exercised prior to each three month extension period to consummate business combination					$ 4,192,000
Over-Allotment Option [Member] | Minimum [Member] | Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Additional amount to be deposit in the trust account if option exercised in each extension period to consummate business					$ 2,096,000
Partial OverAllotment Exercise [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares		960,000
Sale of stock issue price per share		$ 10
Stock Issued During Period, Value, New Issues		$ 9,600,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Summary of Class A Ordinary Shares Subject to Possible Redemption Reflected on the Condensed Balance Sheets (Detail) - Common Class A [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Gross proceeds		$ 209,600,000
Less:
Proceeds allocated to Public Warrants		(3,144,000)
Proceeds allocated to over-allotment option		(20,794)
Class A ordinary shares issuance costs		(12,369,649)
Plus:
Accretion of carrying value to redemption value	$ 2,300,710	23,480,261
Class A ordinary shares subject to possible redemption	$ 219,846,528	$ 217,545,818

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Ordinary Share (Detail) - USD ($)		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Numerator:
Allocation of net income (loss)		$ 2,008,659	$ (37,032)
Common Class A [Member]
Numerator:
Allocation of net income (loss)		$ 1,606,927	$ 0
Denominator:
Basic weighted average ordinary shares outstanding		20,960,000	0
Diluted weighted average ordinary shares outstanding		20,960,000	0
Basic net income (loss) per ordinary share		$ 0.08	$ 0
Diluted net income (loss) per ordinary share		$ 0.08	$ 0
Common Class B [Member]
Numerator:
Allocation of net income (loss)		$ 401,732	$ (37,032)
Denominator:
Basic weighted average ordinary shares outstanding	[1]	5,240,000	5,000,000	[2]
Diluted weighted average ordinary shares outstanding	[1]	5,240,000	5,000,000	[2]
Basic net income (loss) per ordinary share		$ 0.08	$ (0.01)
Diluted net income (loss) per ordinary share		$ 0.08	$ (0.01)
[1]On May 5, 2022, 1,437,500 Class B ordinary shares were surrendered and thereupon cancelled by the Company resulting in a decrease in the total number of Class B ordinary shares outstanding from 7,187,500 shares to 5,750,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (Note 4).[2]This number excludes an aggregate of up to 750,000 Class B ordinary shares that was subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter (Note 4).

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)		3 Months Ended
	Aug. 09, 2022	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Line Items]
Cash insured with federal deposit insurance corporation		$ 250,000
Cash Equivalents, at Carrying Value		$ 0	$ 0
Restricted Investments Term		185 days
Warrant [Member]
Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		17,272,000
Common Class A [Member]
Accounting Policies [Line Items]
Temporary equity, Shares outstanding		20,960,000	20,960,000
Common Class B [Member]
Accounting Policies [Line Items]
Common stock forfeiture during the period	510,000

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)			12 Months Ended
	Jul. 20, 2022	Jun. 28, 2022	Dec. 31, 2022	Mar. 31, 2023
Class of Stock [Line Items]
Deferred underwriting commissions		$ 7,000,000
Share Price				$ 10.25
Public Warrants [Member]
Class of Stock [Line Items]
Number of securities included in unit		0.5
Class A ordinary shares [Member]
Class of Stock [Line Items]
Gross proceeds from initial public offering			$ 209,600,000
Number of securities included in unit		1
Class A ordinary shares [Member] | Public Warrants [Member]
Class of Stock [Line Items]
Class of warrants or rights number of shares called by each warrant or right		1
Class of warrants or rights exercise price per share		$ 11.5
IPO [Member]
Class of Stock [Line Items]
Stock issued during the period shares		20,000,000
Sale of stock issue price per share		$ 10
Gross proceeds from initial public offering		$ 200,000,000
Offering costs		12,000,000
Deferred underwriting commissions		$ 7,000,000
IPO [Member] | Class A ordinary shares [Member]
Class of Stock [Line Items]
Stock issued during the period shares		20,000,000
Gross proceeds from initial public offering		$ 200,000,000
Share Price		$ 10
Over-Allotment Option [Member]
Class of Stock [Line Items]
Sale of stock issue price per share		$ 10
Common stock, shares subscribed but unissued		3,000,000
Partial OverAllotment Exercise [Member]
Class of Stock [Line Items]
Stock issued during the period shares	960,000
Share Price	$ 10
Stock issued during period, value, new issues	$ 9,600,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)

2 Months Ended

3 Months Ended

12 Months Ended

Aug. 09, 2022

Jul. 20, 2022

Jun. 28, 2022

Jun. 23, 2022

May 05, 2022

Feb. 24, 2022

Dec. 09, 2021

Mar. 31, 2022

Mar. 31, 2023

Mar. 31, 2022

Dec. 31, 2022

Dec. 31, 2021

Related Party Transaction [Line Items]

Share Price

$ 10.25

Proceeds from note payable to related party

$ 0

$ 300,000

Additional time frame for completion of business combination

three months each time for a total of up to 24 months

Partial OverAllotment Exercise [Member]

Related Party Transaction [Line Items]

Share Price

$ 10

Stock issued during the period shares

960,000

Extension Loans [Member]

Related Party Transaction [Line Items]

Due to related party

$ 0

$ 0

Private Placement Warrants [Member]

Related Party Transaction [Line Items]

Class of warrant or right, exercise price of warrants or rights

$ 192,000

Class of warrants or rights lock in period post business combination

30 days

Sponsor [Member] | Promissory Note [Member]

Related Party Transaction [Line Items]

Proceeds from note payable to related party

$ 300,000

Repayment of note payable to related party

$ 300,000

Sponsor [Member] | Overfunding Loans [Member]

Related Party Transaction [Line Items]

Debt instrument, face amount

$ 5,000,000

Sponsor [Member] | Overfunding Loans [Member] | Over-Allotment Option [Member]

Related Party Transaction [Line Items]

Debt instrument, face amount

$ 240,000

Sponsor [Member] | Working Capital Loan [Member]

Related Party Transaction [Line Items]

Debt instrument, convertible, conversion price

$ 1

Working capital loans convertible into equity warrants

$ 1,500,000

Due to related party

$ 0

$ 0

Sponsor [Member] | Extension Loans [Member]

Related Party Transaction [Line Items]

Debt instrument, convertible, conversion price

$ 1

Additional per share amount provided funds to deposit into the trust account

$ 0.1

Sponsor [Member] | Administration and Support Services [Member]

Related Party Transaction [Line Items]

Related party transaction, selling, general and administrative expenses from transactions with related party

$ 30,000

Sponsor [Member] | Private Placement Warrants [Member]

Related Party Transaction [Line Items]

Class of warrants or rights warrants issued during the period

192,000

6,600,000

Class of warrants or rights warrants issued issue price per warrant

$ 1

$ 1

Proceeds from issuance of warrants

$ 192,000

$ 6,600,000

Sponsor [Member] | Private Placement Warrants [Member] | Over-Allotment Option [Member]

Related Party Transaction [Line Items]

Class of warrants or rights warrants issued during the period

192,000

Class of warrants or rights warrants issued issue price per warrant

$ 1

Sponsor [Member] | Founder Shares [Member]

Related Party Transaction [Line Items]

Percentage of common stock issued and outstanding

20%

Affiliate Of Sponsor [Member] | Secretarial and Administration Support Services [Member]

Related Party Transaction [Line Items]

Related party transaction amount payable per month

$ 10,000

Common Class B [Member]

Related Party Transaction [Line Items]

Shares issued, price per share

$ 0.0001

$ 0.0001

Shares issued, shares, share-based payment arrangement, forfeited

1,437,500

1,437,500

Shares subject to forfeiture

750,000

750,000

750,000

Common stock, shares, outstanding

5,750,000

5,240,000

5,240,000

5,750,000

Common stock forfeiture during the period

510,000

Common Class B [Member] | Sponsor [Member]

Related Party Transaction [Line Items]

Stock issued during period, shares, issued for services

8,625,000

Shares issued, price per share

$ 0.0001

Stock issued during period, value, issued for services

$ 25,000

$ 25,000

Shares subject to forfeiture

750,000

Common Class B [Member] | Sponsor [Member] | Independent Director Nominees [Member]

Related Party Transaction [Line Items]

Stock issued during period, shares, issued for services

90,000

Common Class B [Member] | Sponsor [Member] | Restriction On Transfer Of Sponsor Shares [Member]

Related Party Transaction [Line Items]

Lock in period of shares

1 year

Class A ordinary shares [Member]

Related Party Transaction [Line Items]

Shares issued, price per share

$ 0.0001

$ 0.0001

Common stock, shares, outstanding

0

0

Proceeds from issuance of warrants

$ 3,144,000

Class A ordinary shares [Member] | Sponsor [Member] | Overfunding Loans [Member]

Related Party Transaction [Line Items]

Debt instrument, convertible, conversion price

$ 10

Class A ordinary shares [Member] | Sponsor [Member] | Restriction On Transfer Of Sponsor Shares [Member]

Related Party Transaction [Line Items]

Share Price

$ 12

Number of trading days for determining share price

20 days

Number of consecutive trading days for determining the share price

30 days

Waiting period after which the share trading days are considered

150 days

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)		3 Months Ended
	Jul. 20, 2022	Mar. 31, 2023
Loss Contingencies [Line Items]
Underwriting Discount Paid Per Unit		$ 0.2
Underwriting Expense Paid		$ 4,000,000
Deferred Underwriting Commission Per Unit		$ 0.35
Deferred Underwriting Commissions Noncurrent		$ 7,000,000
Partial OverAllotment Exercise [Member]
Loss Contingencies [Line Items]
Payment of Additional Underwriter Fee	$ 192,000
Cohen & Company Capital Markets [Member]
Loss Contingencies [Line Items]
Advisory fee		400,000
Deferred advisory fee		700,000
Payment of Additional Underwriter Fee	$ 192,000
Deferred Underwritingand AdvisoryCommissions Net of Reimbursement		336,000
Underwriter [Member]
Loss Contingencies [Line Items]
Deferred Underwritingand AdvisoryCommissions Net of Reimbursement		$ 336,000

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail) - $ / shares			3 Months Ended
	Aug. 09, 2022	Jul. 20, 2022	Mar. 31, 2023	Dec. 31, 2022	May 05, 2022	Mar. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preference shares, par value			$ 0.0001	$ 0.0001
Preference shares,shares authorized			990,000	990,000
Preference shares, issued			0	0
Preference shares, outstanding			0	0
Common stock, conversion basis			one to one
Warrants and Rights Outstanding, Term			5 years
Share Price			$ 10.25
Partial OverAllotment Exercise [Member]
Class of Stock [Line Items]
Share Price		$ 10
Stock issued during the period shares		960,000
Public warrants [Member]
Class of Stock [Line Items]
Number of warrants or rights outstanding			10,480,000	10,480,000
Period after which the warrants are exercisable			30 days
Number of days after consummation of business combination within which the securities shall be registered			15 days
Number of days after which business combination within which securities registration shall be effective			60 days
Volume weighted average price of shares			$ 9.2
Public warrants [Member] | Share Price Equal or Less Nine Point Two Rupees Per Dollar [Member]
Class of Stock [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price			115%
Public warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees Per Dollar [Member]
Class of Stock [Line Items]
Share Redemption Trigger Price			$ 18
Class of warrants, redemption price per unit			$ 0.01
Class of warrants, redemption notice period			30 days
Public warrants [Member] | Share Price Equal or Less Ten Point Zero Rupees Per Dollar [Member]
Class of Stock [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price			180%
Private placement warrants [Member]
Class of Stock [Line Items]
Number of warrants or rights outstanding			6,792,000	6,792,000
Class of warrants or rights lock in period			30 days
Common Class A [Member]
Class of Stock [Line Items]
Ordinary shares, par value			$ 0.0001	$ 0.0001
Ordinary shares,shares authorized			9,000,000,000	9,000,000,000
Common stock, Shares issued			0	0
Common Stock, Shares, Outstanding			0	0
Common Class A [Member] | Share Price Equal or Less Nine Point Two Rupees Per Dollar [Member]
Class of Stock [Line Items]
Proceeds from equity used for funding business combination as a percentage of the total			60%
Number of trading days for determining the share price			20 days
Common Class A [Member] | Public warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees Per Dollar [Member]
Class of Stock [Line Items]
Share Price			$ 18
Number of consecutive trading days for determining share price			20 days
Number of trading days for determining share price			30 days
Common Class B [Member]
Class of Stock [Line Items]
Ordinary shares, par value			$ 0.0001	$ 0.0001
Ordinary shares,shares authorized			999,000,000	999,000,000
Common stock, Shares issued			5,240,000	5,240,000			5,750,000
Common Stock, Shares, Outstanding			5,240,000	5,240,000	5,750,000		5,750,000
Shares subject to forfeiture			750,000			750,000
Common Stock Forfeitured During The Period	510,000
Class A Ordinary Subject to Possible Redemption [Member]
Class of Stock [Line Items]
Common stock, Shares issued			20,960,000
Common Stock, Shares, Outstanding				20,960,000
Founder shares [Member] | Common Class B [Member]
Class of Stock [Line Items]
Percentage of the Company's issued and outstanding shares after the Initial Public Offering			20%
Stock Conversion Basis			one vote for each share
Common stock, threshold percentage on conversion of shares			20%

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities That Are Measured At Fair Value On A Recurring Basis (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account – Money Market Fund	$ 219,946,528	$ 217,645,818
Level 1 [Member] | Fair Value, Recurring [Member] | Money Market Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account – Money Market Fund	219,946,528	217,645,818
Level 2 [Member] | Fair Value, Recurring [Member] | Money Market Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account – Money Market Fund	0	0
Level 3 [Member] | Fair Value, Recurring [Member] | Money Market Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account – Money Market Fund	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net	$ 0